Carlton Precious Announces Filing of Notice of Intention to Sell Athena Gold Corporation Common Shares
Globenewswire· 2025-09-17 19:00
TORONTO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Carlton Precious Inc. (TSX-V: CPI | OTCQB: CPIFF) ("Carlton Precious" or the "Company") announces that the Company has filed a notice of intention to distribute securities (Form 45-102F1) (the “Notice”) in connection with its proposed sale of up to 5 million common shares of Athena Gold Corporation (CSE: ATHA) (“Athena”). The common shares are expected to be sold through the facilities of the Canadian Securities Exchange, and may also be sold or transferred privat ...
Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
Globenewswire· 2025-09-17 19:00
Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: 1) Planning adaptive Phase 2/3 study Approximately 70 million people that are eligible for treatment live in areas of the U.S. in which Lyme Disease is endemic CHATHAM, N.J., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated biopharmaceutical company with marketed products and a pipeline of developme ...
Anfield Receives Approval to List on NASDAQ
Globenewswire· 2025-09-17 19:00
VANCOUVER, British Columbia, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Anfield Energy Inc. (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) (“Anfield” or the “Company”) is pleased to announce it has received approval to list its common shares (the “Shares”) on The Nasdaq Capital Market LLC (“NASDAQ”). Trading is expected to commence on NASDAQ at the open of markets on September 18, 2025, under the symbol “AEC”. Concurrently with the listing, the Shares will cease to be quoted on the OTCQB® Venture Market but will contin ...
Nevada Lithium Announces Significant Amounts of Critical Minerals Rubidium and Cesium Within its Bonnie Claire Lithium Project
Globenewswire· 2025-09-17 19:00
VANCOUVER, British Columbia, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Nevada Lithium Resources Inc. (TSXV: NVLH; OTCQB: NVLHF; FSE: 87K) (“Nevada Lithium” or the “Company”) is pleased to announce significant rubidium (Rb) and cesium (Cs) mineralization has been identified within existing drill core on its 100% owned Bonnie Claire lithium project (the “Project” or “Bonnie Claire”), located in Nye County, Nevada. Initial test work indicates these elements have advanced through the initial lithium/boron recovery sta ...
Baker Hughes Secures Multi-Year Contract with Petrobras for Offshore Stimulation Vessels
Globenewswire· 2025-09-17 19:00
Contract extension for two stimulation vessels supports offshore operations in Brazil’s post and pre-salt fieldsAward reinforces Baker Hughes’ Mature Assets Solutions strategy to deliver greater customer value for enhanced brownfield recovery HOUSTON and LONDON, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Baker Hughes (NASDAQ: BKR), an energy technology company, announced Wednesday a multi-year agreement with Petrobras to extend the deployment of the Blue Marlin and Blue Orca stimulation vessels, supporting optimiza ...
Castle Biosciences Named One of Newsweek's America's Greatest Companies 2025
Globenewswire· 2025-09-17 19:00
FRIENDSWOOD, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has been included in the inaugural 2025 America’s Greatest Companies list, published by Newsweek. The ranking honors 650 U.S. companies demonstrating strong performance across four key pillars: financial strength, workforce dedication, innovation, and commitment to environmental sustainability and corporate ethics. “This recognition from ...
Microbix Client Labquality Introduces Novel EQA Scheme at ESCV
Globenewswire· 2025-09-17 19:00
Supporting Clinical Labs in Accurately Identifying HPV-associated Head and Neck CancersMISSISSAUGA, Ontario and HELSINKI, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and Labquality Oy (Labquality), announce a novel external quality assessment (“EQA”) program to help ensure clinical laboratories accurately identify head and neck cancers associated with cancer-causing strains of Human Papilloma Virus (“ ...
Vertical Aerospace Announces Manufacturing Facilities and Updates on Path to Certification During Capital Markets Day
Businesswire· 2025-09-17 19:00
LONDON & NEW YORK--(BUSINESS WIRE)--Vertical Aerospace (Vertical) [NYSE: EVTL], a global aerospace and technology company that is pioneering electric aviation, will host its Capital Markets Day today in New York City, beginning at 2:00 p.m. ET. The event will provide key updates on the Company's Flightpath 2030 business strategy, certification and manufacturing progress, and financial outlook. A live webcast for the event is available here. Initial Production Facilities Secured Vertical will an. ...
JIM BEAM AND THE CADILLAC FORMULA 1® TEAM ANNOUNCE GLOBAL PARTNERSHIP, FUELING A VISION TO REACH NEW AUDIENCES
Prnewswire· 2025-09-17 19:00
Accessibility StatementSkip Navigation Two American originals united on one world stage CLERMONT, Ky. and FISHERS, Ind., Sept. 17, 2025 /PRNewswire/ --Â Jim Beam®, the world's No. 1 bourbon, and the Cadillac Formula 1® Team, are proud to announce a multi-year global partnership that brings together two of the most iconic names in American culture, now united on the world's fastest stage: Formula 1®. Jim Beam and The Cadillac Formula 1® Team Announce Global Partnership (Image Courtesy of Jim Beam) In 2026, t ...
Kymera Therapeutics Announces Late-Breaking Oral Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the European Academy of Dermatology & Venereology and European Respiratory Society Congresses
Globenewswire· 2025-09-17 19:00
Featured presentations showcase the positive Phase 1 healthy volunteer trial results supporting KT-621’s oral, dupilumab-like profile KT-621 BroADen Phase 1b trial in moderate to severe atopic dermatitis (AD) patients on track to report data in 4Q25 KT-621 Phase 2b trials in AD and asthma on track to initiate in 4Q25 and 1Q26, respectively WATERTOWN, Mass., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral sm ...